Table 2 Item characteristics of the SAQs in the pre- and post-test

Determination of the gestational age

2

1.35 ± 0.56

0.273

0.67

1.36 ± 0.50

0.105

0.68

Maternity report

5

2.78 ± 1.34

0.049

0.56

3.80 ± 0.95

0.198

0.76

Indication for induction of labour

1

0.91 ± 0.29

0.165

0.91

0.94 ± 0.14

0.089

0.98

Induction of labour with medication

3

0.37 ± 0.58

0.094

0.12

0.61 ± 0.75

0.142

0.20

Initial examination/admission delivery room

3

0.34 ± 0.52

0.011

0.11

0.40 ± 0.62

0.357

0.13

Evaluation vaginal results vaginal palpation

2

0.74 ± 0.67

0.334

0.37

1.14 ± 0.62

0.241

0.57

Indication for micro blood examination

2

1.91 ± 0.39

0.308

0.95

2.00 ± 0.01

n/a

1.00

Examination of micro blood examination

1

0.20 ± 0.40

−0.027

0.20

0.81 ± 0.40

0.270

0.81

Evaluation of APGAR-score and umbilical cord BGA

2

1.61 ± 0.78

0.162

0.81

1.73 ± 0.59

0.308

0.86

Assessment of the CTG according to FIGO

4

3.31 ± 1.37

0.263

0.83

3.60 ± 0.95

−0.116

0.90

Definition of heavy menstruation

1

0.53 ± 0.50

0.154

0.53

0.51 ± 0.50

0.111

0.51

Definition of irregular menstruation

1

0.75 ± 0.44

0.262

0.75

0.71 ± 0.46

0.105

0.71

Differential diagnoses of atypical bleeding

2

1.41 ± 0.76

0.226

0.71

1.30 ± 0.80

0.230

0.65

Primary prevention of cervical carcinoma

2

1.49 ± 0.50

0.056

0.75

1.39 ± 0.51

0.079

0.70

Evaluation of the acetic acid test

2

1.23 ± 0.72

0.126

0.62

1.24 ± 0.48

0.176

0.62

Most frequent histological form cervical carcinoma*

1

1.00 ± 0.01

n/a

1.00

0.99 ± 0.10

−0.035

0.99

Metastasis of cervical carcinoma

1

0.85 ± 0.36

0.291

0.85

0.93 ± 0.26

0.300

0.93

Prerequisites for the R0 situation

2

1.80 ± 0.43

0.203

0.90

1.72 ± 0.50

0.054

0.86

Therapy of cervical carcinoma

1

0.94 ± 0.23

0.271

0.94

0.98 ± 0.14

0.397

0.98

Follow-up care for cervical carcinoma

2

1.07 ± 0.82

−0.030

0.54

0.91 ± 0.81

0.076

0.45

Initial examination on admission to the delivery room

4

1.63 ± 0.85

0.101

0.41

1.99 ± 0.98

0.239

0.50

Differential diagnoses third trimester bleeding

4

2.21 ± 0.73

0.136

0.55

2.44 ± 0.72

0.229

0.61

Bishop score

1

0.69 ± 0.46

0.090

0.69

0.41 ± 0.50

0.123

0.41

Assessment of vaginal palpation

1

0.77 ± 0.42

0.289

0.77

0.84 ± 0.37

0.352

0.84

Biometry of the fetus

3

0.48 ± 0.87

0.142

0.16

0.10 ± 0.50

0.090

0.03

Assessment of the CTG according to FIGO

1

0.99 ± 0.10

0.143

0.99

0.98 ± 0.14

0.006

0.98

First measures in case of CTG decelerations

1

0.49 ± 0.50

0.058

0.49

0.40 ± 0.49

0.016

0.40

Measures in case of repeated CTG delays

1

0.84 ± 0.37

0.301

0.84

0.65 ± 0.48

0.163

0.65

Definition criteria for the APGAR score

5

4.93 ± 0.53

0.493

0.99

5.00 ± 0.01

n/a

1.00

Evaluation of the Apgar score

1

0.82 ± 0.39

0.292

0.82

0.87 ± 0.34

0.350

0.87

Imaging procedure Breast cancer diagnosis*

1

1.00 ± 0.01

n/a

1.00

1.00 ± 0.01

n/a

1.00

Differential diagnoses benign breast tumours

4

3.61 ± 0.91

0.059

0.90

3.76 ± 0.50

0.229

0.94

Hereditary risk factors for breast cancer

2

1.62 ± 0.69

0.281

0.81

1.87 ± 0.42

0.215

0.93

Clinical signs of breast cancer

3

2.26 ± 0.88

0.173

0.75

2.26 ± 0.86

0.181

0.75

Risk lesions/pre-cancerous lesions Breast cancer

3

2.87 ± 0.39

0.098

0.96

2.88 ± 0.46

0.380

0.96

Prerequisites for curative therapy approach

1

0.84 ± 0.37

0.246

0.84

0.88 ± 0.33

0.101

0.88

Postoperative approach in an R0 situation

1

0.79 ± 0.41

0.335

0.79

0.93 ± 0.26

0.268

0.93

Metastases in breast cancer

3

2.87 ± 0.49

0.179

0.96

2.90 ± 0.42

0.269

0.97

Prognostic receptor factors in breast cancer

3

2.97 ± 0.23

0.217

0.99

2.95 ± 0.26

0.366

0.98

Other carcinomas that are caused by BRCA mutation

1

0.99 ± 0.10

0.056

0.99

0.99 ± 0.10

0.004

0.99